𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Budd-chiari syndrome in patients with hematological disease: A therapeutic challenge

✍ Scribed by Subhas C. Ganguli; Nizar N. Ramzan; Michael A. McKusick; James C. Andrews; Robert L. Phyliky; Patrick S. Kamath

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
94 KB
Volume
27
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis

Advances in radiological imaging studies have simplified the diagnosis of Budd-Chiari syndrome (BCS), but many challenges still remain with respect to therapy. Patients with BCS who have a hematological disorder are an especially difficult group to treat. Major issues related to the treatment of BCS in these patients include the role of thrombolytic therapy, anticoagulation, and shunt surgery or transjugular intrahepatic portosystemic shunts (TIPS); the indications for and risks of liver transplantation; as well as control of the underlying hematological disease.

πŸ“œ SIMILAR VOLUMES

Eighteen years of liver transplantation
Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome
✍ Frank Ulrich; Johann Pratschke; Ulf Neumann; Andreas Pascher; Gero Puhl; Peter F πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 217 KB

The long-term results of liver transplantation for Budd-Chiari syndrome (BCS) and timely indication for the procedure are still under debate. Innovations in interventional therapy and better understanding of underlying diseases have improved therapy strategies. The aim of this study was the analysis

Use of thromboelastography PlateletMappi
Use of thromboelastography PlateletMappingβ„’ to monitor antithrombotic therapy in a patient with Budd-Chiari syndrome
✍ Katherine James; Elisa Bertoja; James O'Beirne; Susan Mallett πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 311 KB

Budd-Chiari syndrome (BCS) is the end result of a number of disease states resulting in hepatic venous outflow obstruction. We report a Janus kinase 2-homozygous patient with BCS who thrombosed a transjugular intrahepatic portosystemic shunt (TIPS) despite treatment with warfarin (international norm

Budd-chiari syndrome associated with fac
Budd-chiari syndrome associated with factor V leiden mutation: A report of 6 patients
✍ Hoffman, Ron ;Nimer, Assy ;Lanir, Naomi ;Brenner, Benjamin ;Baruch, Yaacov πŸ“‚ Article πŸ“… 1999 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 56 KB

Budd-Chiari syndrome is characterized by hepatic venous outflow obstruction. Although myeloproliferative disorders are usually responsible for this severe thrombotic disorder, deficiency or dysfunction of the natural anticoagulants can be involved. Resistance to activated protein C caused by factor

Systemic hemodynamics, vasoactive system
Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome
✍ Manuel HernΓ‘ndez-Guerra; Eric LΓ³pez; Pablo Bellot; Carlos Piera; Juan Turnes; Ju πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 124 KB

Budd-Chiari syndrome (BCS) causes postsinusoidal portal hypertension, which leads to complications similar to those observed in cirrhosis. However, no studies have investigated whether patients with BCS develop the hyperdynamic circulatory syndrome present in patients with cirrhosis who have portal

Determinants of survival and the effect
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome
✍ Sarwa Darwish Murad; Dominique-Charles Valla; Piet C. de Groen; Guy Zeitoun; Jud πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 134 KB

Budd-Chiari syndrome (BCS) is a rare disorder that is characterized by hepatic venous outflow obstruction. The aim of this study was to assess determinants of survival and to evaluate the effect of portosystemic shunting. In this international multicenter study, 237 patients with BCS, diagnosed betw